Key result
Heart rate variability biofeedback beats sham for depression without clear autonomic modulation.
Why the study?
Heart rate variability biofeedback is presumed to act via baroreflex resonance and vagal afferent signaling, but it remained unclear whether sham-controlled trial evidence supports this specific autonomic mechanism over non-specific psychological factors.
Does heart rate variability biofeedback improve clinical and psychological outcomes through a specific autonomic mechanism compared to a valid sham condition?
Does heart rate variability biofeedback improve clinical and psychological outcomes through a specific autonomic mechanism compared to a valid sham condition?
Current sham-controlled trial evidence suggests that while the clinical effects of heart rate variability biofeedback are likely genuine, they may be substantially driven by non-specific psychological factors rather than the classically proposed baroreflex-resonance autonomic mechanism.
Answers are grounded in this paper and cite their sources.
HRV biofeedback mood benefits may reflect non-specific effects; challenges baroreflex model and leaves specific mechanisms open.
INTRODUCTION. Heart rate variability biofeedback (HRV-BFB) is a widely used non-pharmacological technique based on slow, resonance-frequency breathing (~6 breaths/min), presumed to act through a specific autonomic mechanism involving baroreflex resonance and vagal afferent signaling. AIM. To critically evaluate whether the proposed specific autonomic mechanism of HRV-BFB is supported by sham-controlled trial evidence, or whether its clinical effects are better explained by non-specific psychological factors. MATERIALS AND METHODS. A narrative review of the literature was conducted using PubMed, Scopus, and Google Scholar (1996–2026), focusing on randomized controlled trials with a valid sham condition, systematic reviews and meta-analyses, and neuroimaging studies of HRV-BFB. RESULTS AND DISCUSSION. The classical baroreflex-resonance model is supported by several physiological studies (increased baroreflex gain, specificity of the individual resonance frequency). However, the small set of trials employing a valid sham condition presents a mixed picture: in one of the most methodologically rigorous trials to date (N = 47), HRV-BFB outperformed sham on affect and depression outcomes but produced no specific modulation of autonomic nervous system activity. Other sham-controlled trials (in critical illness polyneuropathy and traumatic brain injury) yield conflicting results. A comparison of individually determined resonance frequency against a fixed 0.1 Hz rate found no significant difference in clinical efficacy. CONCLUSION. The clinical effects of HRV-BFB are probably genuine, but current sham-controlled evidence does not unambiguously confirm the specific autonomic mechanism proposed by the classical baroreflex-resonance model. Non-specific mechanisms – prefrontal self-regulation and expectation effects – may contribute substantially. Future trials should assess psychological and autonomic outcomes simultaneously within a valid sham-controlled design.
No takes yet. Share an insight, caveat, or question.
Es’haghi et al. (2026) conducted a review in Autonomic modulation, depression, critical illness polyneuropathy, and traumatic brain injury. Heart rate variability biofeedback (HRV-BFB) vs. Sham biofeedback or fixed 0.1 Hz breathing rate was evaluated on Specific autonomic nervous system modulation and clinical efficacy. Heart rate variability biofeedback outperformed sham on depression in a rigorous trial (N=47) without specific autonomic modulation, leaving its baroreflex mechanism unconfirmed.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: